Laboratorios Farmacéuticos Rovi SA (LABFF)
OTC
Closed
Oct 7, 2026
Day's Range
67.1752 wk Range
67.17Overview - LABFF - Laboratorios Farmacéuticos Rovi SA
Key Statistics
Valuation
Enterprise Value
3.86B
P/E (Trailing)
15.91
Price / Sales (TTM)
4.44
Price / Book
4.35
EV / EBITDA
19.50
Profitability
Gross Margin
68.67%
Profit Margin
23.95%
Operating Margin
9.41%
Return on Assets
9.44%
Return on Equity
28.65%
Ownership
Shares Outstanding
51.14M
Float
16.20M
Held by Insiders
68.19%
Held by Institutions
16.66%
Price stats
Beta
0.26
50-Day Avg
69.05
200-Day Avg
85.22
Dividends
Payout Ratio
25.83%
Frequency
Annual
Shariah Compliance
Report Date: Feb 17, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - LABFF - Laboratorios Farmacéuticos Rovi SA
Peers - LABFF - Laboratorios Farmacéuticos Rovi SA
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on OTC.
- LABFFOTCLaboratorios Farmacéuticos Rovi SA3.43BMarket Cap-34.90%52-week change15.92P/E (Trailing)23.95%Profit Margin
- MKGAFOTCMerck KGaA67.92BMarket Cap+9.27%52-week change25.32P/E (Trailing)11.21%Profit Margin
- MKKGYOTCMerck KGaA Sponsored ADR67.10BMarket Cap+8.97%52-week change24.90P/E (Trailing)11.21%Profit Margin
- GALDYOTCGalderma Group AG Unsponsored ADR45.20BMarket Cap+7.87%52-week change53.10P/E (Trailing)14.57%Profit Margin
- GDERFOTCGalderma Group AG44.15BMarket Cap+11.81%52-week change51.88P/E (Trailing)14.57%Profit Margin
- JHPCYOTCJiangsu Hengrui Pharmaceuticals Co. Ltd.43.14BMarket Cap-30.46%52-week change37.14P/E (Trailing)86.20%Profit Margin
- HLNCFOTCHaleon plc38.69BMarket Cap+1.79%52-week change18.58P/E (Trailing)14.55%Profit Margin
Profile Summary - LABFF - Laboratorios Farmacéuticos Rovi SA
About
Laboratorios Farmacéuticos Rovi SA is a Spanish biotechnology and pharmaceutical company specializing in the research, development, manufacturing, and marketing of small molecule and specialty biologic drugs. Founded in 1946, it operates through two primary segments: Manufacturing, focused on contract development and…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
